ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 46 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,415 | -31.5% | 46,721 | 0.0% | 0.00% | – |
| Q4 2022 | $7,910 | -12.1% | 46,721 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -60.9% | 46,721 | 0.0% | 0.00% | – |
| Q2 2022 | $23,000 | -11.5% | 46,721 | 0.0% | 0.00% | – |
| Q1 2022 | $26,000 | -7.1% | 46,721 | 0.0% | 0.00% | – |
| Q4 2021 | $28,000 | -37.8% | 46,721 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $45,000 | -11.8% | 46,721 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $51,000 | +15.9% | 46,721 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $44,000 | +100.0% | 46,721 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | -40.5% | 46,721 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $37,000 | +48.0% | 46,721 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $25,000 | +47.1% | 46,721 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $17,000 | – | 46,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |